Clinical trial
Open access
Aug 2026
A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project
Background Migraine is a highly prevalent disease and the leading cause of years lived with disability in women. The development of therapies targeting the calcitonin gene-related peptide (CGRP) pathway has provided the first mechanism-based approach for migraine prevention. Although these treatments have demonstrated...
D. Martinelli, E. Caronna, H. Basedau et al.
· Frontiers in Neurology · 0 citations